Effect of Nebulized Magnesium Sulfate on Post-intubation Stress Response in Patients Undergoing Laparoscopic Cholecystectomy
Effect of Preoperative Nebulized Magnesium Sulfate on Post-intubation Stress Response in Patients Undergoing Laparoscopic Cholecystectomy
1 other identifier
interventional
140
0 countries
N/A
Brief Summary
This randomized controlled double blinded study will be carried out on 140 patients underwent elective fit laparoscopic cholecystectomy at El-Rajhi Assiut University Hospital. Inclusion criteria:
- 20-50 years old.
- Both sexes.
- American society of anesthesiologists (ASA) physical status I-II.
- Elective fit laparoscopic cholecystectomy Exclusion criteria:
- Patient refusal.
- Patients with history of hypersensitivity to magnesium sulfate.
- Patients with coronary ischemic disease, atrioventricular block of any degree, known cardiac arrhythmias, heart failure on beta blockers or calcium channel blockers expected difficult intubation (Mallampati 4).
- Body mass index (BMI) \> 40 kg/m2. An online randomization program (http://www.randomizer.org) will be used to generate a random list and each patients' code will be kept in an opaque sealed envelope. Patients will be randomly allocated with 1:1 allocation ratio into two equal groups in a parallel manner:
- Group A: (N=70) Patients will receive nebulized magnesium sulfate in 5 ml (250 mg) over 15 min.
- Group B: (N=70) Patients received nebulized normal saline in 5 ml over 15 min, ending 5 min before the induction of anesthesia. A. Preoperative assessment: All patients will be subjected to the followings:
- Demographic data collection (age, weight, height, BMI, and ASA).
- Complete clinical examination.
- Routine Laboratory investigations:
- Random blood sugar.
- Blood sample withdrawal for cortisol level at baseline 2ml intravenously. The sample will be sent to be centrifugated within 30 minutes and the serum will be separated and stored in -20°C till time of cortisol level by ELIZA technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2025
CompletedFirst Posted
Study publicly available on registry
August 14, 2025
CompletedStudy Start
First participant enrolled
August 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2025
CompletedAugust 14, 2025
August 1, 2025
2 months
August 8, 2025
August 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference between preoperative cortisol level and 6minutes after intubation
cortisol level will be measured preoperatively and 6 minutes after intubation then calculation of the difference between them then comparison between both groups
6 minutes after intubation
Secondary Outcomes (3)
NRS for sore throat postoperatively
24 hours
4 grade scale
24 hours postoperatively
Random blood sugar RBS
6 minutes after intubation
Study Arms (2)
Nebulized magnesium sulfate group
EXPERIMENTALPatients will receive nebulized magnesium sulfate in 5 ml (250 mg) over 15 min.
control group
NO INTERVENTIONPatients will receive nebulized normal saline 5ml, 15 minutes preoperatively
Interventions
patient will be nebulized with 5 mg magnesium sulfate (5 ml) 15 minutes before induction of anesthesia
Eligibility Criteria
You may qualify if:
- American society of anesthesiologists (ASA) physical status I-II.
- Elective fit laparoscopic cholecystectomy
You may not qualify if:
- Patient refusal.
- Patients with history of hypersensitivity to magnesium sulphate.
- Patients with coronary ischemic disease, atrioventricular block of any degree, known cardiac arrhythmias, heart failure on beta blockers or calcium channel blockers expected difficult intubation (Mallampati 4).
- Body mass index (BMI) \> 40 kg/m2.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Yadav M, Chalumuru N, Gopinath R. Effect of magnesium sulfate nebulization on the incidence of postoperative sore throat. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):168-71. doi: 10.4103/0970-9185.173367.
PMID: 27275043BACKGROUND2. Gutiérrez-Román, C.I., O. Carrillo-Torres and E.S. Pérez-Meléndez, Uses of magnesium sulfate in anesthesiology. Revista médica del Hospital General de México, 2022. 85(1): p. 25-33, .
BACKGROUNDChen Z, Zuo Z, Zhang L, Gong M, Ye Y, Jin Y, Zhao X. Postoperative Sore Throat After Tracheal Intubation: An Updated Narrative Review and Call for Action. J Pain Res. 2025 May 6;18:2285-2306. doi: 10.2147/JPR.S498933. eCollection 2025.
PMID: 40352818BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
August 8, 2025
First Posted
August 14, 2025
Study Start
August 20, 2025
Primary Completion
November 1, 2025
Study Completion
November 10, 2025
Last Updated
August 14, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share